Anomer-equilibrated streptozotocin solution for the induction of experimental diabetes in mice (Mus musculus)

Journal of the American Association for Laboratory Animal Science

Volumn 49, Issue 1, 2010, Pages 40-44

  De La Garza Rodea, Anabel S ^a   Knaän Shanzer, Shoshan ^a   Den Hartigh, Jan D ^a   Verhaegen, Alphons P L ^a   Van Bekkum, Dirk W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOMER; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETOGENESIS; EPIMER; FEMALE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; MALE; MORTALITY; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; REPRODUCIBILITY; SCID MOUSE; STREPTOZOCIN DIABETES;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, EXPERIMENTAL; DRUG STABILITY; DRUG STORAGE; INJECTIONS, INTRAPERITONEAL; ISOMERISM; MICE; SOLUTIONS; STREPTOZOCIN;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 76349090901     PISSN: 15596109     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Animal Models of Diabetic Complications Consortium. [Internet]. 2003. Low-dose streptozotocin induction protocol (mouse). [Cited 15 Sep 2006]. Available at http://www.amdcc.org/shared/showFile.aspx?doctypeid=3&docid=19
2. Ceylan-Isik AF, LaCour KH, Ren J. 2006. Sex difference in cardiomyocyte function in normal and metallothionein transgenic mice: the effect of diabetes mellitus. J Appl Physiol 100:1638-1646.
3. Brosius FC. 2008. Personal communication.
4. Gurley SB, Clare SE, Snow KP, Hu A, Meyer TW, Coffman TM. 2006. Impact of genetic background on nephropathy in diabetic mice. Am J Physiol Renal Physiol 290:F214-F222.
5. Hayashi K, Kojima R, Ito M. 2006. Strain differences in the diabetogenic activity of streptozotocin in mice. Biol Pharm Bull 29:1110-1119.
6. Hegde KR, Henein MG, Varma SD. 2003. Establishment of mouse as an animal model for study of diabetic cataracts: biochemical studies. Diabetes Obes Metab 5:113-119.
7. Hermann M, Pirkebner D, Draxl A, Berger P, Untergasser G, Margreiter R, Hengster P. 2007. Dickkopf 3 is expressed in a subset of adult human pancreatic β cells. Histochem Cell Biol 127:513-521.
8. Keswani SG, Katz AB, Lim FY, Zoltick P, Radu A, Alaee D, Herlyn M, Crombleholme TM. 2004. Adenoviral mediated gene transfer of PDGFB enhances wound healing in type I and type II diabetic wounds. Wound Repair Regen 12:497-504.
9. Lee RH, Seo MJ, Reger RL, Spees JL, Pulin AA, Olson SD, Prockop DJ. 2006. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/Scid mice. Proc Natl Acad Sci USA 103:17438-17443.
10. Leiter E. 2008. Personal communication.
11. Oles PJ. 1978. High-pressure liquid chromatographic separation and determination of anomeric forms of streptozocin in a powder formulation. J Pharm Sci 67:1300-1302.
12. Povoski SP, McCullough PJ, Zhou W, Bell RH Jr. 1993. Induction of diabetes mellitus in Syrian golden hamsters using stored equilibrium solutions of streptozotocin. Lab Anim Sci 43:310-314.
13. Rees DA, Alcolado JC. 2005. Animal models of diabetes mellitus. Diabet Med 22:359-370.
14. Rossini AA, Like AA, Chick WL, Appel MC, Cahill GF Jr. 1977. Studies of streptozotocin-induced insulitis and diabetes. Proc Natl Acad Sci USA 74:2485-2489.
15. Rossini AA, Like AA, Dulin WE, Cahill GF Jr. 1977. Pancreatic beta cell toxicity by streptozotocin anomers. Diabetes 26:1120-1124.
16. Sigma-Aldrich Chemical Company. 2008. Personal communication.
17. Schnedl WJ, Ferber S, Johnson JH, Newgard CB. 1994. STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 43:1326-1333.
18. Strosberg J, Hoffe S, Gardner N, Choi J, Kvols L. 2007. Effective treatment of locally advanced endocrine tumors of the pancreas with chemoradiotherapy. Neuroendocrinology 85:216-220.
19. Vijayan S, Zhou P, Rajapaksha TW, Alegre ML, Peter ME. 2005. Transplanted islets from lpr mice are resistant to autoimmune destruction in a model of streptozotocin-induced type I diabetes. Apoptosis 10:725-730.
20. Weber C, Pernis B, Ting W, Rosenkrantz K, Reemtsma K. 1984. Murine streptozotocin diabetes: influences of the major histocompatibility complex, genetic background, and blood transfusion. Diabetologia 27 Suppl:160-162.